{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:57:04Z","timestamp":1786489024947,"version":"build-2736575974"},"reference-count":138,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chinese Scholarship Council","award":["202006170049"],"award-info":[{"award-number":["202006170049"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Systemic lupus erythematosus (SLE) is a complex autoimmune disease in which kidney involvement, so-called lupus nephritis (LN), is common and one of the most severe manifestations. Oxidative stress (OS) may play a role in the pathogenesis of LN through the exacerbation of inflammation and immune cell dysfunction\/dysregulation. Nuclear factor erythroid 2-related factor 2 (Nrf2), also known as nuclear factor erythroid-derived 2-like 2, is a transcription factor that in humans is encoded by the NFE2L2 gene and is regarded as a central regulator of the antioxidative response. Nrf2-activating compounds have been shown to alleviate oxidative stress in cells and tissues of lupus-prone mice. Although the precise mechanisms of Nrf2 activation on the immune system in SLE remain to be elucidated, Nrf2-activating compounds are considered novel therapeutical options to suppress OS and thereby might alleviate disease activity in SLE, especially in LN. This review therefore summarizes the role of the Nrf2 signaling pathway in the pathogenesis of SLE with LN and describes compounds modulating this pathway as potential additional clinical interventions.<\/jats:p>","DOI":"10.3390\/antiox13101224","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T04:02:58Z","timestamp":1728878578000},"page":"1224","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Role of Antioxidant Transcription Factor Nrf2 and Its Activating Compounds in Systemic Lupus Erythematosus"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9274-1372","authenticated-orcid":false,"given":"Lu","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"de Leeuw","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6670-1577","authenticated-orcid":false,"given":"Harry","family":"van Goor","sequence":"additional","affiliation":[{"name":"Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6581-6508","authenticated-orcid":false,"given":"Johanna","family":"Westra","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"ITC81","DOI":"10.7326\/AITC202006020","article-title":"Systemic Lupus Erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus","volume":"56","author":"Mok","year":"2003","journal-title":"J. Clin. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/ard-2023-223880","article-title":"Annals of the Rheumatic Diseases collection on lupus nephritis (2019\u20132022): Novel insights and advances in therapy","volume":"82","author":"Kostopoulou","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41584-023-00925-5","article-title":"Treatment of lupus nephritis: Consensus, evidence and perspectives","volume":"19","author":"Mok","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/rheumatology\/ker101","article-title":"Assessment of a lupus nephritis cohort over a 30-year period","volume":"50","author":"Croca","year":"2011","journal-title":"Rheumatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"393","author":"Durcan","year":"2019","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"103446","DOI":"10.1016\/j.autrev.2023.103446","article-title":"Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?","volume":"23","author":"Mathian","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-med-043021-032611","article-title":"Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches","volume":"74","author":"Lazar","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"108445","DOI":"10.1016\/j.clim.2020.108445","article-title":"Update on the cellular and molecular aspects of lupus nephritis","volume":"216","author":"Frangou","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrrheum.2013.147","article-title":"Oxidative stress in the pathology and treatment of systemic lupus erythematosus","volume":"9","author":"Perl","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Bourgonje, A.R., Kloska, D., Grochot-Przeczek, A., Feelisch, M., Cuadrado, A., and van Goor, H. (2023). Personalized redox medicine in inflammatory bowel diseases: An emerging role for HIF-1alpha and NRF2 as therapeutic targets. Redox Biol., 60.","DOI":"10.1016\/j.redox.2023.102603"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1089\/ars.2017.7083","article-title":"The Reactive Species Interactome: Evolutionary Emergence, Biological Significance, and Opportunities for Redox Metabolomics and Personalized Medicine","volume":"27","author":"Koning","year":"2017","journal-title":"Antioxid. Redox Signal"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive oxygen species, toxicity, oxidative stress, and antioxidants: Chronic diseases and aging","volume":"97","author":"Jomova","year":"2023","journal-title":"Arch. Toxicol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5152\/eurasianjmed.2018.17397","article-title":"Reactive Oxygen Species: The Dual Role in Physiological and Pathological Conditions of the Human Body","volume":"50","author":"Bardaweel","year":"2018","journal-title":"Eurasian J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative Stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2016.05.007","article-title":"The pathogenesis of systemic lupus erythematosus\u2014From the viewpoint of oxidative stress and mitochondrial dysfunction","volume":"30","author":"Lee","year":"2016","journal-title":"Mitochondrion"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Shah, D., Mahajan, N., Sah, S., Nath, S.K., and Paudyal, B. (2014). Oxidative stress and its biomarkers in systemic lupus erythematosus. J. Biomed. Sci., 21.","DOI":"10.1186\/1423-0127-21-23"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ene, C.D., Georgescu, S.R., Tampa, M., Matei, C., Mitran, C.I., Mitran, M.I., Penescu, M.N., and Nicolae, I. (2021). Cellular Response against Oxidative Stress, a Novel Insight into Lupus Nephritis Pathogenesis. J. Pers. Med., 11.","DOI":"10.3390\/jpm11080693"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Lin, D.W., Hsu, Y.C., Chang, C.C., Hsieh, C.C., and Lin, C.L. (2023). Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076053"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1523-1755.2001.00939.x","article-title":"Nrf2-deficient female mice develop lupus-like autoimmune nephritis","volume":"60","author":"Yoh","year":"2001","journal-title":"Kidney Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"He, F., Ru, X., and Wen, T. (2020). NRF2, a Transcription Factor for Stress Response and Beyond. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134777"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ngo, V., and Duennwald, M.L. (2022). Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease. Antioxidants, 11.","DOI":"10.3390\/antiox11122345"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional Regulation by Nrf2","volume":"29","author":"Tonelli","year":"2018","journal-title":"Antioxid. Redox Signal"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/MCB.25.1.162-171.2005","article-title":"BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase","volume":"25","author":"Furukawa","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bcp.2012.11.016","article-title":"The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation","volume":"85","author":"Bryan","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.molmed.2023.07.008","article-title":"The NRF2\/Keap1 pathway as a therapeutic target in inflammatory bowel disease","volume":"29","author":"Geertsema","year":"2023","journal-title":"Trends Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Barati, M.T., and Caster, D.J. (2022). The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus Erythematosus. Metabolites, 12.","DOI":"10.3390\/metabo12020151"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"101756","DOI":"10.1016\/j.arr.2022.101756","article-title":"Role of Nrf2 in aging, Alzheimer\u2019s and other neurodegenerative diseases","volume":"82","author":"George","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5478708","DOI":"10.1155\/2020\/5478708","article-title":"Oxidative Stress in the Pathophysiology of Kidney Disease: Implications for Noninvasive Monitoring and Identification of Biomarkers","volume":"2020","author":"Gyuraszova","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Aranda-Rivera, A.K., Cruz-Gregorio, A., Aparicio-Trejo, O.E., and Pedraza-Chaverri, J. (2021). Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases. Biomolecules, 11.","DOI":"10.3390\/biom11081144"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Chung, S., Kim, S., Son, M., Kim, M., Koh, E.S., Shin, S.J., Park, C.W., and Kim, H.S. (2019). Inhibition of p300\/CBP-Associated Factor Attenuates Renal Tubulointerstitial Fibrosis through Modulation of NF-kB and Nrf2. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20071554"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.2147\/DMSO.S271290","article-title":"LncRNA SNHG16 Aggravates High Glucose-Induced Podocytes Injury in Diabetic Nephropathy Through Targeting miR-106a and Thereby Up-Regulating KLF9","volume":"13","author":"He","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e001126","DOI":"10.1136\/lupus-2023-001126","article-title":"Machine learning-based identification of novel hub genes associated with oxidative stress in lupus nephritis: Implications for diagnosis and therapeutic targets","volume":"11","author":"Zeng","year":"2024","journal-title":"Lupus Sci. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"107482","DOI":"10.1016\/j.intimp.2021.107482","article-title":"Heme supplementation ameliorates lupus nephritis through rectifying the disorder of splenocytes and alleviating renal inflammation and oxidative damage","volume":"94","author":"Wu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e1168","DOI":"10.1002\/iid3.1168","article-title":"Cordyceps cicadae ameliorates inflammatory responses, oxidative stress, and fibrosis by targeting the PI3K\/mTOR-mediated autophagy pathway in the renal of MRL\/lpr mice","volume":"12","author":"Yang","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Gao, W., Guo, L., Yang, Y., Wang, Y., Xia, S., Gong, H., Zhang, B.K., and Yan, M. (2021). Dissecting the Crosstalk Between Nrf2 and NF-kappaB Response Pathways in Drug-Induced Toxicity. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.809952"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/BST20150014","article-title":"Dissecting molecular cross-talk between Nrf2 and NF-kappaB response pathways","volume":"43","author":"Wardyn","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Liu, P., Ma, G., Wang, Y., Wang, L., and Li, P. (2023). Therapeutic effects of traditional Chinese medicine on gouty nephropathy: Based on NF-kappaB signalingpathways. Biomed. Pharmacother., 158.","DOI":"10.1016\/j.biopha.2022.114199"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nutres.2022.09.001","article-title":"Bioactive compounds modulating Toll-like 4 receptor (TLR4)-mediated inflammation: Pathways involved and future perspectives","volume":"107","author":"Almeida","year":"2022","journal-title":"Nutr. Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kelley, N., Jeltema, D., Duan, Y., and He, Y. (2019). The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133328"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Guerrero-Hue, M., Rayego-Mateos, S., Vazquez-Carballo, C., Palomino-Antolin, A., Garcia-Caballero, C., Opazo-Rios, L., Morgado-Pascual, J.L., Herencia, C., Mas, S., and Ortiz, A. (2020). Protective Role of Nrf2 in Renal Disease. Antioxidants, 10.","DOI":"10.3390\/antiox10010039"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e15961","DOI":"10.14814\/phy2.15961","article-title":"NRF2 in kidney physiology and disease","volume":"12","author":"Bondi","year":"2024","journal-title":"Physiol. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/pr.117.014753","article-title":"Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach","volume":"70","author":"Cuadrado","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/j.1523-1755.2004.00565.x","article-title":"Nrf2 deficiency improves autoimmune nephritis caused by the fas mutation lpr","volume":"65","author":"Morito","year":"2004","journal-title":"Kidney Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ki.2013.343","article-title":"Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-\u03baB-mediated inflammatory response","volume":"85","author":"Jiang","year":"2014","journal-title":"Kidney Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12969-023-00909-5","article-title":"Potential regulatory role of the Nrf2\/HMGB1\/TLR4\/NF-\u03baB signaling pathway in lupus nephritis","volume":"21","author":"Li","year":"2023","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/art.41383","article-title":"NF-E2-Related Factor 2 Regulates Interferon Receptor Expression and Alters Macrophage Polarization in Lupus","volume":"72","author":"Han","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Zhao, M., Chen, H., Ding, Q., Xu, X., Yu, B., and Huang, Z. (2016). Nuclear Factor Erythroid 2-related Factor 2 Deficiency Exacerbates Lupus Nephritis in B6\/lpr mice by Regulating Th17 Cell Function. Sci. Rep., 6.","DOI":"10.1038\/srep38619"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.2353\/ajpath.2006.051113","article-title":"Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2","volume":"168","author":"Ma","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.14348\/molcells.2023.0028","article-title":"Molecular Basis of the KEAP1-NRF2 Signaling Pathway","volume":"46","author":"Suzuki","year":"2023","journal-title":"Mol. Cells"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"105853","DOI":"10.1016\/j.phrs.2021.105853","article-title":"The pivotal role of Nrf2 activators in adipocyte biology","volume":"173","author":"Jayasuriya","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1152\/physiolgenomics.00209.2003","article-title":"Genetic dissection of systemic autoimmune disease in Nrf2-deficient mice","volume":"18","author":"Li","year":"2004","journal-title":"Physiol. Genom."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.freeradbiomed.2011.05.016","article-title":"Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation","volume":"51","author":"Tsai","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/art.33328","article-title":"Antroquinonol differentially modulates T cell activity and reduces interleukin-18 production, but enhances Nrf2 activation, in murine accelerated severe lupus nephritis","volume":"64","author":"Tsai","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s13075-015-0844-6","article-title":"Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activation","volume":"17","author":"Ka","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jnutbio.2015.09.017","article-title":"Dietary extra virgin olive oil attenuates kidney injury in pristane-induced SLE model via activation of HO-1\/Nrf-2 antioxidant pathway and suppression of JAK\/STAT, NF-kappaB and MAPK activation","volume":"27","author":"Cardeno","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13075-016-1039-5","article-title":"Nuclear factor erythroid 2-related factor 2 is a critical target for the treatment of glucocorticoid-resistant lupus nephritis","volume":"18","author":"Ebihara","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Bonomini, F., Dos Santos, M., Veronese, F.V., and Rezzani, R. (2019). NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143466"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Castejon, M.L., S\u00e1nchez-Hidalgo, M., Aparicio-Soto, M., Montoya, T., Mart\u00edn-LaCave, I., Fern\u00e1ndez-Bola\u00f1os, J.G., and Alarc\u00f3n-de-la-Lastra, C. (2019). Dietary oleuropein and its new acyl-derivate attenuate murine lupus nephritis through HO-1\/Nrf2 activation and suppressing JAK\/STAT, NF-\u03baB, MAPK and NLRP3 inflammasome signaling pathways. J. Nutr. Biochem., 74.","DOI":"10.1016\/j.jnutbio.2019.108229"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2019.08.013","article-title":"Protective effect of dihydroartemisinin in inhibiting senescence of myeloid-derived suppressor cells from lupus mice via Nrf2\/HO-1 pathway","volume":"143","author":"Li","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13075-019-1876-0","article-title":"Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2\/HO-1 in myeloid-derived suppressor cells","volume":"21","author":"Li","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s11427-020-1840-1","article-title":"Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets. Science China","volume":"64","author":"Lin","year":"2021","journal-title":"Life Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"115643","DOI":"10.1016\/j.jep.2022.115643","article-title":"Jieduquyuziyin prescription promotes the efficacy of prednisone via upregulating Nrf2 in MRL\/lpr kidneys","volume":"298","author":"Du","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"115004","DOI":"10.1016\/j.jep.2022.115004","article-title":"Esculetin alleviates murine lupus nephritis by inhibiting complement activation and enhancing Nrf2 signaling pathway","volume":"288","author":"Zhang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"112140","DOI":"10.1016\/j.foodres.2022.112140","article-title":"Oleocanthal supplemented diet improves renal damage and endothelial dysfunction in pristane-induced systemic lupus erythematosus in mice","volume":"163","author":"Montoya","year":"2023","journal-title":"Food Res. Int."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Munoz-Garcia, R., Sanchez-Hidalgo, M., Alcarranza, M., Vazquez-Roman, M.V., de Sotomayor, M.A., Gonzalez-Rodriguez, M.L., de Andres, M.C., and Alarcon-de-la-Lastra, C. (2023). Effects of Dietary Oleacein Treatment on Endothelial Dysfunction and Lupus Nephritis in Balb\/C Pristane-Induced Mice. Antioxidants, 12.","DOI":"10.3390\/antiox12061303"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Nezu, M., and Suzuki, N. (2020). Roles of Nrf2 in Protecting the Kidney from Oxidative Damage. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082951"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbrc.2004.06.112","article-title":"Identification of polymorphisms in the promoter region of the human NRF2 gene","volume":"321","author":"Yamamoto","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1177\/0961203310367917","article-title":"The NRF2 gene variant, -653G\/A, is associated with nephritis in childhood-onset systemic lupus erythematosus","volume":"19","author":"Cordova","year":"2010","journal-title":"Lupus"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2020.06.025","article-title":"The role of Nrf2 in acute kidney injury: Novel molecular mechanisms and therapeutic approaches","volume":"158","author":"Wei","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1177\/0961203320950022","article-title":"Altered redox regulation by Nrf2-Keap1 system in dendritic cells of systemic lupus erythematosus patients","volume":"29","author":"Gautam","year":"2020","journal-title":"Lupus"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1177\/0961203320959441","article-title":"Altered oxidative stress markers in relation to T cells, NK cells & killer immunoglobulin receptors that are associated with disease activity in SLE patients","volume":"29","author":"Tandon","year":"2020","journal-title":"Lupus"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Li, J., Guo, Q., Wei, X., Zhu, Y., Luo, M., and Luo, P. (2024). Association of serum Nrf2 protein levels with disease activity and renal impairment in lupus nephritis. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1304167"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1159\/000495400","article-title":"4-Octyl Itaconate Activates Nrf2 Signaling to Inhibit Pro-Inflammatory Cytokine Production in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients","volume":"51","author":"Tang","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1093\/rheumatology\/kead547","article-title":"Taxifolin inhibits NETosis through activation of Nrf2 and provides protective effects in models of lupus and antiphospholipid syndrome","volume":"63","author":"Rysenga","year":"2023","journal-title":"Rheumatology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/med.21567","article-title":"Dimethyl fumarate, a two-edged drug: Current status and future directions","volume":"39","author":"Saidu","year":"2019","journal-title":"Med. Res. Rev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.freeradbiomed.2004.02.075","article-title":"Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles","volume":"36","author":"Itoh","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.redox.2017.10.010","article-title":"Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy","volume":"14","author":"Cuadrado","year":"2018","journal-title":"Redox Biol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Matteo, P., Federico, D., Emanuela, M., Giulia, R., Tommaso, B., Alfredo, G., Anna, C., and Annamaria, O. (2022). New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14122732"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1177\/0961203316644335","article-title":"Fumaric acid ester treatment in cutaneous lupus erythematosus (CLE): A prospective, open-label, phase II pilot study","volume":"25","author":"Kuhn","year":"2016","journal-title":"Lupus"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/nutrit\/nuaa129","article-title":"Cruciferous vegetables: Rationale for exploring potential salutary effects of sulforaphane-rich foods in patients with chronic kidney disease","volume":"79","author":"Cardozo","year":"2021","journal-title":"Nutr. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Mahn, A., and Castillo, A. (2021). Potential of Sulforaphane as a Natural Immune System Enhancer: A Review. Molecules, 26.","DOI":"10.3390\/molecules26030752"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Yagishita, Y., Fahey, J.W., Dinkova-Kostova, A.T., and Kensler, T.W. (2019). Broccoli or Sulforaphane: Is It the Source or Dose That Matters?. Molecules, 24.","DOI":"10.3390\/molecules24193593"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Liebman, S.E., and Le, T.H. (2021). Eat Your Broccoli: Oxidative Stress, NRF2, and Sulforaphane in Chronic Kidney Disease. Nutrients, 13.","DOI":"10.3390\/nu13010266"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2009.04.004","article-title":"Repeated intake of broccoli does not lead to higher plasma levels of sulforaphane in human volunteers","volume":"284","author":"Hanlon","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Kubo, E., Chhunchha, B., Singh, P., Sasaki, H., and Singh, D.P. (2017). Sulforaphane reactivates cellular antioxidant defense by inducing Nrf2\/ARE\/Prdx6 activity during aging and oxidative stress. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-14520-8"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"21592","DOI":"10.1074\/jbc.M300931200","article-title":"Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression","volume":"278","author":"McMahon","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jnutbio.2014.12.008","article-title":"Sulforaphane attenuation of experimental diabetic nephropathy involves GSK-3 beta\/Fyn\/Nrf2 signaling pathway","volume":"26","author":"Shang","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1002\/ptr.7176","article-title":"Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials","volume":"35","author":"Mangla","year":"2021","journal-title":"Phytother. Res."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Jin, Q., Liu, T., Chen, D., Yang, L., Mao, H., Ma, F., Wang, Y., Li, P., and Zhan, Y. (2023). Therapeutic potential of artemisinin and its derivatives in managing kidney diseases. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1097206"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-020-04170-5","article-title":"Artemisinin-type drugs for the treatment of hematological malignancies","volume":"87","author":"Mancuso","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: Pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Xia, M., Liu, D., Liu, Y., and Liu, H. (2020). The Therapeutic Effect of Artemisinin and Its Derivatives in Kidney Disease. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00380"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1038\/s41401-022-00978-4","article-title":"Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases: Therapeutic effects and molecular mechanisms","volume":"43","author":"Tong","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11926-018-0764-y","article-title":"Artemisinins\u2014A Promising New Treatment for Systemic Lupus Erythematosus: A Descriptive Review","volume":"20","author":"Mu","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.phymed.2018.09.011","article-title":"Pentacyclic triterpenes: New tools to fight metabolic syndrome","volume":"50","author":"Sharma","year":"2018","journal-title":"Phytomedicine"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pbi.2006.03.004","article-title":"Biosynthetic diversity in plant triterpene cyclization","volume":"9","author":"Phillips","year":"2006","journal-title":"Curr. Opin. Plant Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3390\/molecules20011610","article-title":"Triterpenes as potentially cytotoxic compounds","volume":"20","author":"Chudzik","year":"2015","journal-title":"Molecules"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3390\/molecules14062016","article-title":"Pentacyclic triterpene distribution in various plants\u2014Rich sources for a new group of multi-potent plant extracts","volume":"14","author":"Jager","year":"2009","journal-title":"Molecules"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"9965","DOI":"10.1021\/acs.jmedchem.0c01088","article-title":"CDDO-imidazolide Targets Multiple Amino Acid Residues on the Nrf2 Adaptor, Keap1","volume":"63","author":"Meng","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_104","first-page":"2075","article-title":"Bardoxolone methyl (CDDO-Me) as a therapeutic agent: An update on its pharmacokinetic and pharmacodynamic properties","volume":"8","author":"Wang","year":"2014","journal-title":"Drug Des. Devel Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2215\/CJN.02400222","article-title":"Effects of Bardoxolone Methyl in Alport Syndrome","volume":"17","author":"Warady","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/ndt\/gfac242","article-title":"Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: Design and baseline characteristics of the AYAME study","volume":"38","author":"Nangaku","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update","volume":"36","author":"Lu","year":"2016","journal-title":"Med. Res. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"Akizawa","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"127535","DOI":"10.1016\/j.foodchem.2020.127535","article-title":"Polyphenols and their applications: An approach in food chemistry and innovation potential","volume":"338","author":"Pastore","year":"2021","journal-title":"Food Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1039\/C3FO60361J","article-title":"Phenolic compounds: Their journey after intake","volume":"5","author":"Chen","year":"2014","journal-title":"Food Funct."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Jin, Q., Liu, T., Qiao, Y., Liu, D., Yang, L., Mao, H., Ma, F., Wang, Y., Peng, L., and Zhan, Y. (2023). Oxidative stress and inflammation in diabetic nephropathy: Role of polyphenols. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1185317"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Rahman, M.M., Rahaman, M.S., Islam, M.R., Rahman, F., Mithi, F.M., Alqahtani, T., Almikhlafi, M.A., Alghamdi, S.Q., Alruwaili, A.S., and Hossain, M.S. (2021). Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects. Molecules, 27.","DOI":"10.3390\/molecules27010233"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Andres, C.M.C., Perez de la Lastra, J.M., Bustamante Munguira, E., Juan, C.A., Plou, F.J., and Perez Lebena, E. (2024). Electrophilic Compounds in the Human Diet and Their Role in the Induction of the Transcription Factor NRF2. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063521"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/j.jrn.2016.06.005","article-title":"Effects of Resveratrol Supplementation in Nrf2 and NF-kappaB Expressions in Nondialyzed Chronic Kidney Disease Patients: A Randomized, Double-Blind, Placebo-Controlled, Crossover Clinical Trial","volume":"26","author":"Saldanha","year":"2016","journal-title":"J. Ren. Nutr."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2147\/CIA.S223805","article-title":"Recovery of Bone And Muscle Mass in Patients with Chronic Kidney Disease and Iron Overload on Hemodialysis and Taking Combined Supplementation with Curcumin and Resveratrol","volume":"14","year":"2019","journal-title":"Clin. Interv. Aging"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2337\/diabetes.52.5.1204","article-title":"A low-iron-available, polyphenol-enriched, carbohydrate-restricted diet to slow progression of diabetic nephropathy","volume":"52","author":"Facchini","year":"2003","journal-title":"Diabetes"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1601080","DOI":"10.1002\/mnfr.201601080","article-title":"The phenolic fraction of extra virgin olive oil modulates the activation and the inflammatory response of T cells from patients with systemic lupus erythematosus and healthy donors","volume":"61","author":"Cardeno","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1124\/jpet.105.090399","article-title":"Inhibition of autoantigen expression by (-)-epigallocatechin-3-gallate (the major constituent of green tea) in normal human cells","volume":"315","author":"Hsu","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3892\/mmr.2024.13306","article-title":"Potential of resveratrol in the treatment of systemic lupus erythematosus (Review)","volume":"30","author":"Huo","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"ref_120","first-page":"867","article-title":"The impact of agonists and antagonists of TLR3 and TLR9 on concentrations of IL-6, IL10 and sIL-2R in culture supernatants of peripheral blood mononuclear cells derived from patients with systemic lupus erythematosus","volume":"71","author":"Robak","year":"2017","journal-title":"Postep. Hig. Med. Dosw."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2174\/0115733971276106231226071002","article-title":"Randomised Clinical Trial Study: The Combination of Vitamin D and Curcumin Piperine Attenuates Disease Activity and Pro-inflammatory Cytokines Levels Insystemic Lupus Erythematosus Patients","volume":"20","author":"Wahono","year":"2024","journal-title":"Curr. Rheumatol. Rev."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.jrn.2011.03.002","article-title":"Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: A randomized and placebo-controlled study","volume":"22","author":"Khajehdehi","year":"2012","journal-title":"J. Ren. Nutr."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Han, Y., Liu, L., Zang, B., Liang, R., Zhao, X., and Liu, B. (2023). Advances in natural products and antibody drugs for SLE: New therapeutic ideas. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1235440"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Mannucci, C., Casciaro, M., Sorbara, E.E., Calapai, F., Di Salvo, E., Pioggia, G., Navarra, M., Calapai, G., and Gangemi, S. (2021). Nutraceuticals against Oxidative Stress in Autoimmune Disorders. Antioxidants, 10.","DOI":"10.3390\/antiox10020261"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Islam, M.A., Khandker, S.S., Kotyla, P.J., and Hassan, R. (2020). Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01477"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1017\/S0954422417000026","article-title":"An update on diet and nutritional factors in systemic lupus erythematosus management","volume":"30","year":"2017","journal-title":"Nutr. Res. Rev."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Kono, M., Nagafuchi, Y., Shoda, H., and Fujio, K. (2021). The Impact of Obesity and a High-Fat Diet on Clinical and Immunological Features in Systemic Lupus Erythematosus. Nutrients, 13.","DOI":"10.3390\/nu13020504"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.nut.2012.01.015","article-title":"Nutritional status and food intake in patients with systemic lupus erythematosus","volume":"28","author":"Borges","year":"2012","journal-title":"Nutrition"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Alunno, A., Carubbi, F., Bartoloni, E., Grassi, D., Ferri, C., and Gerli, R. (2021). Diet in Rheumatoid Arthritis versus Systemic Lupus Erythematosus: Any Differences?. Nutrients, 13.","DOI":"10.3390\/nu13030772"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s11926-013-0378-3","article-title":"Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus","volume":"15","author":"Greco","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/jren.2000.16323","article-title":"Lupus erythematosus and nutrition: A review of the literature","volume":"10","author":"Brown","year":"2000","journal-title":"J. Ren. Nutr."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"A267","DOI":"10.1016\/j.autrev.2009.12.001","article-title":"Nutrition, geoepidemiology, and autoimmunity","volume":"9","author":"Selmi","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"ref_133","first-page":"22","article-title":"Personalized Nutrition and Lifestyle Interventions in Systemic Lupus Erythematosus: A Case Report","volume":"21","author":"Kielmann","year":"2023","journal-title":"Integr. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/rheumatology\/keaa210","article-title":"Beneficial effect of Mediterranean diet on disease activity and cardiovascular risk in systemic lupus erythematosus patients: A cross-sectional study","volume":"60","year":"2021","journal-title":"Rheumatology"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/j.gastro.2008.06.082","article-title":"Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer","volume":"135","author":"Shibata","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.tibs.2008.12.008","article-title":"NRF2 and KEAP1 mutations: Permanent activation of an adaptive response in cancer","volume":"34","author":"Hayes","year":"2009","journal-title":"Trends Biochem. Sci."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.0702027104","article-title":"Regulation of the protein disulfide proteome by mitochondria in mammalian cells","volume":"104","author":"Yang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.2337\/db13-1743","article-title":"Derivative of bardoxolone methyl, dh404, in an inverse dose-dependent manner lessens diabetes-associated atherosclerosis and improves diabetic kidney disease","volume":"63","author":"Tan","year":"2014","journal-title":"Diabetes"}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/13\/10\/1224\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:11:43Z","timestamp":1760112703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/13\/10\/1224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":138,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["antiox13101224"],"URL":"https:\/\/doi.org\/10.3390\/antiox13101224","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]}}}